e-Clinical Solutions Market Growth, Trends, Industry Statistics 2022-2030

The global e-clinical solutions market size is expected to be worth around US$ 22.7 billion by 2030, according to a new report by Vision Research Reports.

The global e-clinical solutions market size was valued at US$ 7.9 billion in 2020 and is anticipated to grow at a CAGR of 13.7% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38878

Report Coverage

Report Scope Details
Market Size USD 22.7 Billion by 2030
Growth Rate CAGR of 13.7% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, delivery mode, development phase, end-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Datatrak International, Inc.; Oracle; Parexel International Corporation; Dassault Systemes; Bioclinica; Datatrak International, Inc.; CRF Health; ERT Clinical; eClinicalWorks; IBM; Anju Life Sciences Software; eClinical Solutions

Growth Factors

Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage a huge influx of specimens on a daily basis.

Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth. Besides this, the growing incorporation of software solutions in clinical trials is also projected to drive the market for eClinical solutions.

By Product Analysis

The CTMS segment dominated the market for eClinical solutions and accounted for the largest revenue share of 20.9% in 2020. eCOA is estimated to be the fastest-growing segment during the forecast period owing to the rising significance of high-quality clinical data.

Elimination of data variance risk streamlined information and lowering of site monitoring cost are key advantages associated with eCOA. These aforementioned benefits are expected to fuel its demand in the coming years.

By Delivery Mode Analysis

The web-hosted segment dominated the market for eClinical solutions and accounted for the largest revenue share of around 75.2% in 2020. The dominance of the segment can be attributed to associated benefits such as easy accessibility, usability, and lower investments required.

The cloud-based segment is anticipated to exhibit an exponential CAGR of 14.3% during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup.

By Development Phase Analysis

On the basis of the development phase, the phase III segment dominated the market for eClinical solutions and accounted for the largest revenue share of 52.9% in 2020. The spiraling need for the incorporation of clinical data management software to curb overall cost and improve process efficiency is contributing to the growth of the segment.

The phase I segment is estimated to be the most promising segment during the forecast period owing to the high significance of these systems to predict future outcomes and eliminate drug candidates possessing the least probability of success.

By End-use Analysis

 The CROs segment dominated the market for eClinical solutions and held the largest revenue share of 37.8% in 2020. The segment is projected to rise at a remarkable CAGR during the forecast period owing to the growing inclination of pharmaceutical companies to reduce overall expenditure.

Benefits involved in outsourcing clinical trials to CROs are responsible for the heightened growth of this segment. These benefits include cost advantages, increased efficiency of services, enhanced productivity, and a higher focus on core areas of development critical to a company’s growth.

By Regional Analysis

North America dominated the eClinical solutions market and accounted for the largest revenue share of 53.1% in 2020. The increasing target population, coupled with the rising prevalence of lifestyle-associated diseases such as diabetes and cardiac disorders, is poised to stimulate the growth of the market.

In Asia Pacific, the market for eClinical solutions is likely to register a noteworthy CAGR at 15.5% over the forecast period. High unmet medical needs and the rising prevalence of target chronic diseases such as cancer, cardiovascular conditions, and infectious diseases are stoking the demand for software solutions in the region

Key Players

  • Datatrak International, Inc.
  • Oracle
  • Parexel International Corporation
  • Dassault Systemes
  • Bioclinica
  • Datatrak International, Inc.
  • CRF Health
  • ERT Clinical
  • eClinicalWorks
  • IBM
  • Anju Life Sciences Software
  • eClinical Solutions

Market Segmentation

  • By Product
    • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
    • Clinical Trial Management Systems (CTMS)
    • Clinical Analytics Platforms
    • Randomization and Trial Supply Management (RTSM)
    • Clinical Data Integration Platforms
    • Electronic Clinical Outcome Assessment (eCOA)
    • Safety Solutions
    • Electronic Trial Master File (eTMF)
  • By Delivery Mode
    • Web-hosted (On demand)
    • Licensed Enterprise (On premise)
    • Cloud-based
  • By Development Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • By End-use
    • Hospitals/Healthcare providers
    • CROs
    • Academic Institutes
    • Pharma & Biotech Organizations
    • Medical Device Manufacturers
  • Regional
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Netherlands
      • Sweden
      • Denmark
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Australia
      • New Zealand
      • Taiwan
      • Hong Kong
      • Singapore
      • Thailand
      • Vietnam
    • Central & South America
      • Brazil
      • Argentina
      • Chile
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Egypt
      • Qatar

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38878

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Development Phase Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global E-Clinical Solutions Market, By Product

7.1.  E-Clinical Solutions Market, by Product, 2021-2030

7.1.1.    Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Clinical Trial Management Systems (CTMS)

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Clinical Analytics Platforms

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Randomization and Trial Supply Management (RTSM)

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Clinical Data Integration Platforms

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Electronic Clinical Outcome Assessment (eCOA)S)

7.1.6.1.        Market Revenue and Forecast (2017-2030)

7.1.7.    Safety Solutions

7.1.7.1.        Market Revenue and Forecast (2017-2030)

7.1.8.    Electronic Trial Master File (eTMF)

7.1.8.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global E-Clinical Solutions Market, By Delivery Mode

8.1.  E-Clinical Solutions Market, by Delivery Mode, 2021-2030

8.1.1.    Web-hosted (On demand)

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Licensed Enterprise (On premise)

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Cloud-based

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global E-Clinical Solutions Market, By Development Phase

9.1.  E-Clinical Solutions Market, by Development Phase, 2021-2030

9.1.1.    Phase I

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Phase II

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Phase III

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Phase IV

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global E-Clinical Solutions Market, By End-user

10.1.        E-Clinical Solutions Market, by End-user, 2021-2030

10.1.1.  Hospitals/Healthcare providers

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  CROs

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Academic Institutes

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Pharma & Biotech Organizations

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Medical Device Manufacturers

10.1.5.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global E-Clinical Solutions Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2017-2030)

11.1.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.1.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2017-2030)

11.2.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2017-2030)

11.3.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2017-2030)

11.4.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2017-2030)

11.5.2.  Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.5.3.  Market Revenue and Forecast, by Development Phase (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-user (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-user (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Delivery Mode (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Development Phase (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-user (2017-2030)

Chapter 12.  Company Profiles

12.1.              Datatrak International, Inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Oracle

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Parexel International Corporation

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Dassault Systemes

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bioclinica

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Datatrak International, Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              CRF Health

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              ERT Clinical

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              eClinicalWorks

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           IBM

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38878

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com